Emerging Treatment Pathways for HFrEF Patients: What Does the Evidence Say?

Drs Anker, Hernandez, and Vaduganathan discuss the potential role of cardiac myosin activators in the treatment of patients with HFrEF. Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/939935?src=mkm_podcast_addon_939935